Energy News / Shareholders Foundation, Inc.

NASDAQ:ZIOP Investor Alert: Investigation over Potential Wrongdoing at ZIOPHARM Oncology, Inc

Via: ReleaseWire

Updated 11:00 AM CDT, Fri, August 31,2018

An investigation on behalf of investors in ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) shares over potential wrongdoing at ZIOPHARM Oncology, Inc. was announced.

San Diego, CA -- (SBWIRE) -- 08/31/2018 -- An investigation was announced for investors in shares of ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) concerning potential breaches of fiduciary duties by certain officers and directors at ZIOPHARM Oncology, Inc.

Investors, who purchased shares of ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain ZIOPHARM Oncology, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders.

Boston, MA based ZIOPHARM Oncology, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing a portfolio of immuno-oncology therapies for treating heterogenous solid tumors and unknown antigens. Shares of ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) declined to as low as $2.23 per share on August 6, 2018.

On August 30, 2018, NASDAQ: ZIOP shares closed at $2.75 per share.

Those who purchased shares of ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP), have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

For more information on this press release visit:
http://www.sbwire.com/press-releases/nasdaqziop-investor-alert-investigation-over-potential-wrongdoing-at-ziopharm-oncology-inc-1039827.htm

Media Relations Contact
Michael Daniels
858-779-1554
Email: Click to Email Michael Daniels
Web: http://www.ShareholdersFoundation.com